166 related articles for article (PubMed ID: 32949634)
1. Effects of polyhydroxyfullerenes on organophosphate-induced toxicity in mice.
Ehrich M; Hinckley J; Werre SR; Zhou Z
Toxicology; 2020 Dec; 445():152586. PubMed ID: 32949634
[TBL] [Abstract][Full Text] [Related]
2. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
[TBL] [Abstract][Full Text] [Related]
3. Microglia Remodelling and Neuroinflammation Parallel Neuronal Hyperactivation Following Acute Organophosphate Poisoning.
Somkhit J; Yanicostas C; Soussi-Yanicostas N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897817
[TBL] [Abstract][Full Text] [Related]
4. Comparative study on short- and long-term behavioral consequences of organophosphate exposure: relationship to AChE mRNA expression.
López-Granero C; Cardona D; Giménez E; Lozano R; Barril J; Aschner M; Sánchez-Santed F; Cañadas F
Neurotoxicology; 2014 Jan; 40():57-64. PubMed ID: 24291005
[TBL] [Abstract][Full Text] [Related]
5. The role of oxidative stress in organophosphate and nerve agent toxicity.
Pearson JN; Patel M
Ann N Y Acad Sci; 2016 Aug; 1378(1):17-24. PubMed ID: 27371936
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase.
Coban A; Carr RL; Chambers HW; Willeford KO; Chambers JE
Toxicol Lett; 2016 Apr; 248():39-45. PubMed ID: 26965078
[TBL] [Abstract][Full Text] [Related]
7. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
8. A single dose of the organophosphate triazophos induces fear extinction deficits accompanied by hippocampal acetylcholinesterase inhibition.
Rodrigues JVF; Vidigal APP; Minassa VS; Batista TJ; de Lima RMS; Funck VR; Antero LS; Resstel LBM; Coitinho JB; Bertoglio LJ; Sampaio KN; Beijamini V
Neurotoxicol Teratol; 2020; 82():106929. PubMed ID: 33031921
[TBL] [Abstract][Full Text] [Related]
9. Cell-Membrane-Cloaked Oil Nanosponges Enable Dual-Modal Detoxification.
Chen Y; Zhang Y; Zhuang J; Lee JH; Wang L; Fang RH; Gao W; Zhang L
ACS Nano; 2019 Jun; 13(6):7209-7215. PubMed ID: 31117372
[TBL] [Abstract][Full Text] [Related]
10. Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review.
Lorke DE; Petroianu GA
J Appl Toxicol; 2019 Jan; 39(1):101-116. PubMed ID: 30027640
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.
Rosenberg Y; Saxena A
Neuropharmacology; 2020 Sep; 174():108150. PubMed ID: 32442543
[TBL] [Abstract][Full Text] [Related]
12. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
13. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
[TBL] [Abstract][Full Text] [Related]
14. Modelling organophosphate intoxication in C. elegans highlights nicotinic acetylcholine receptor determinants that mitigate poisoning.
Izquierdo PG; Charvet CL; Neveu C; Green AC; Tattersall JEH; Holden-Dye L; O'Connor V
PLoS One; 2023; 18(4):e0284786. PubMed ID: 37083685
[TBL] [Abstract][Full Text] [Related]
15. The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors.
Soukup O; Jun D; Tobin G; Kuca K
Arch Toxicol; 2013 Apr; 87(4):711-9. PubMed ID: 23179755
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning.
Masson P; Nachon F
J Neurochem; 2017 Aug; 142 Suppl 2():26-40. PubMed ID: 28542985
[TBL] [Abstract][Full Text] [Related]
18. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
19. Use of OpdA, an organophosphorus (OP) hydrolase, prevents lethality in an African green monkey model of acute OP poisoning.
Jackson CJ; Carville A; Ward J; Mansfield K; Ollis DL; Khurana T; Bird SB
Toxicology; 2014 Mar; 317():1-5. PubMed ID: 24447378
[TBL] [Abstract][Full Text] [Related]
20. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
